Assembly Biosciences (ASMB) Return on Sales (2017 - 2026)

Assembly Biosciences' Return on Sales history runs 9 years deep, the most recent figure standing at 0.01% for Q1 2026.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 1.0% from the prior year.
• Return on Sales slipped to 0.01% in Q1 2026 per ASMB's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2025 and bottomed at 0.15% in Q1 2023.
• The 4-year median for Return on Sales is 0.01% (2024), against an average of 0.03%.
• Biggest YoY gain for Return on Sales was 13 bps in 2024; the steepest drop was 0 bps in 2024.
• Year by year, Return on Sales stood at 0.02% in 2023, then climbed by 8 bps to 0.01% in 2024, then surged by 137 bps to 0.01% in 2025, then slumped by 374 bps to 0.01% in 2026.
• Per Business Quant, the three latest ASMB Return on Sales figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).